Dibenzazecine compounds with a novel dopamine/5HT2Areceptor profile and 3D-QSAR analysis

Citations of this article
Mendeley users who have this article in their library.


Background: Antipsychotics are divided into typical and atypical compounds based on clinical efficacy and side effects. The purpose of this study was to characterize in vitro a series of novel azecine-type compounds at human dopamine D1-D5and 5HT2Areceptors and to assign them to different classes according to their dopamine/5HT2Areceptor profile. Results: Regardless of using affinity data (pK1values at D1-D5and 5HT2A) or selectivity data (15 log (K1, ratios)), principal component analysis with azecine-type compounds, haloperidol, and clozapine revealed three groups of dopamine/5HT2Aligands: 1) haloperidol; 2) clozapine plus four azecine-type compounds; 3) two hydroxylated dibenzazecines. Reducing the number of K1, ratios used for principal component analysis from 15 to two (the D1/D2and D2/5HT2AK1ratios) obtained the same three groups of compounds. The most potent dibenzazecine clustering in the same group as clozapine was the non-hydroxylated LE410 which shows a slightly different D2-like receptor profile (D2L> D3 > D4.4) than clozapine (D4.4> D2L> D3). The monohydroxylated dibenzacezine LE404 clusters in a separate group from clozapine/LE410 and from haloperidol and shows increased D1, selectivity. Conclusion: In conclusion, two compounds with a novel dopamine/ 5HT2Areceptor profile, LE404 and LE410, with some differences in their respective D1/D2receptor affinities including a validated pharmacophore-based 3D-QSAR model for D1antagonists are presented. © 2006 Hamacher et al; licensee Biomed Central Ltd.




Hamacher, A., Weigt, M., Wiese, M., Hoefgen, B., Lehmann, J., & Kassack, M. U. (2006). Dibenzazecine compounds with a novel dopamine/5HT2Areceptor profile and 3D-QSAR analysis. BMC Pharmacology, 6. https://doi.org/10.1186/1471-2210-6-11

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free